Predicting bacillus Calmette-Guerin immunotherapy effectiveness.
Griffith
Thomas S
TS
D001500:BCG Vaccine / Q000627:therapeutic use*; D002295:Carcinoma, Transitional Cell / Q000276:immunology / Q000401:mortality / Q000628:therapy*; D005260:Female; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008297:Male; D010865:Pilot Projects; D011237:Predictive Value of Tests; D011379:Prognosis; D016019:Survival Analysis; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000276:immunology / Q000401:mortality / Q000628:therapy*
D001500:BCG Vaccine